Gastric Acid Suppression Is Associated with an Increased Risk of Adverse Outcomes in Inflammatory Bowel Disease

Publisher： Karger

E-ISSN： 1421-9867|95|3|188-193

ISSN： 0012-2823

Source： Digestion, Vol.95, Iss.3, 2017-03, pp. : 188-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do Acid-Suppressing Medications in Inflammatory Bowel Disease Increase Risk for Flare?

By  

Digestion, Vol. 95, Iss. 3, 2017-03 ,pp. : 186-187

Karger

Access to resources Recommend Favorite

Siblings and the Risk of Inflammatory Bowel Disease

By Montgomery S. M.   Lambe M.   Wakefield A. J.   Pounder R. E.   Ekbom A.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 11, 2002-11 ,pp. : 1301-1308

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory Bowel Disease-Specific Autoantibodies in HLA-B27-Associated Spondyloarthropathies: Increased Prevalence of ASCA and pANCA

By  

Digestion, Vol. 70, Iss. 1, 2004-09 ,pp. : 49-54

Karger

Access to resources Recommend Favorite

The surgical treatment of inflammatory bowel disease-associated dysplasia

By Connelly Tara M   Koltun Walter A  

Expert Review of Gastroenterology and Hepatology, Vol. 7, Iss. 4, 2013-05 ,pp. : 307-322

Informa Healthcare

Access to resources Recommend Favorite

Treatment of arthralgias and spondyloarthropathy associated with inflammatory bowel disease

By Becker Heidemarie   Gaubitz Markus   Domschke Wolfram   Kucharzik Torsten  

Future Rheumatology, Vol. 2, Iss. 4, 2007-08 ,pp. : 423-431

Future Medicine

Access to resources Recommend Favorite